The most effective combination of pharmacological therapy for heart failure with reduced ejection fraction: a network meta-analysis of randomized controlled trials
Abstract Background Evidence for the efficacy of pharmacological therapies for heart failure with reduced ejection fraction (HFrEF) is growing. However, there is no consensus on the most effective treatment for HFrEF. This study aimed to evaluate the most effective combination of pharmacological the...
Saved in:
| Main Authors: | Huilin Tang, Kimberly Germinal, Alexandra Milfort, Wei-Han Chen, Shao-Hsuan Chang, Wenxi Huang, Yujia Li, Ying Lu, Mustafa M. Ahmed, Stephen E. Kimmel, Jiang Bian, Jingchuan Guo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | BMC Cardiovascular Disorders |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12872-024-04339-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings
by: Maria del Carmen Asensio-Lopez, et al.
Published: (2025-04-01) -
Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement
by: S. N. Tereshchenko, et al.
Published: (2020-06-01) -
Elevating Expectations: Vericiguat in Heart Failure with Reduced Ejection Fraction
by: Pushpraj Patel, et al.
Published: (2024-12-01) -
Correlation of β-adrenergic reactivity of erythrocyte membranes with clinical characteristics of patients with coronary artery disease and HF with preserved and reduced ejection fraction
by: E. F. Muslimova, et al.
Published: (2025-01-01) -
Catestatin as a predictor for cardiac death in heart failure with mildly reduced and preserved ejection fraction
by: Song‐Yun Chu, et al.
Published: (2025-02-01)